Skip to content

Clinical study on the promotion of postoperative wound repair of anal fistula by Chuangyue liquid dressing

Clinical study on the promotion of postoperative wound repair of anal fistula by Chuangyue liquid dressing

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092666
Enrollment
Unknown
Registered
2024-11-21
Start date
2024-11-22
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anal fistula

Interventions

Experimental Group:fter anal fistula resection, the wound was smeared with Chuangyue liquid dressing.
Control group:After anal fistula resection, the wound was smeared with Kangfuxin solution.

Sponsors

Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of low anal fistula; 2. Between the ages of 18 and 65, male and female. 3. Patients who agree to participate in clinical trial observation and sign a consent form, and who are able to complete follow-up visits. 4. Reviewed by the Hospital Ethics Committee.

Exclusion criteria

Exclusion criteria: 1. Specific anal fistulae due to ulcerative colitis, Crohn's, tuberculosis, or other unexplained infections; 2. Previous history of anal fistula and other anal surgical procedures; 3. Combined cardiovascular, cerebrovascular, hepatic, renal, hematologic and other serious diseases, psychiatric patients; 4. Pregnant and lactating women; 5. Allergy or hypersensitivity to the drugs that make up this preparation; 6. Those who use other medications that have the potential to affect the results of the study. 7. Being involved in a multi-subject study as well as not wishing to join this study; 8. Those who did not meet the inclusion criteria, were unable to judge efficacy or had incomplete information, etc., which affected the judgment of efficacy or safety.

Design outcomes

Primary

MeasureTime frame
rate of change in wound area;

Secondary

MeasureTime frame
wound healing time;growth of granulation tissue;pain index;wound exudation;serum fibronectin concentration;serum IL-6 concentration;overall efficacy evaluation;

Countries

China

Contacts

Public ContactHou Yi

Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine

xunziyang2015@163.com+86 132 6076 5789

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026